Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.97% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EWCZ
3051
DELISTED
European Wax Center
EWCZ
| $290K | ﹤0.01% |
+43,500
| New | +$286K |
|
3052
Korn Ferry
KFY
$4.28B
| $290K | ﹤0.01% |
4,300
-21,200
| -83% | -$1.54M |
|
|
LND
3053
BrasilAgro
LND
$348M
| $290K | ﹤0.01% |
80,300
-35,746
| -31% | -$147K |
|
3054
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.11B
| $288K | ﹤0.01% |
+6,296
| New | +$294K |
|
3055
Citizens Community Bancorp
CZWI
$200M
| $288K | ﹤0.01% |
17,674
-10,826
| -38% | -$165K |
|
3056
Curis
CRIS
$3.91M
| $288K | ﹤0.01% |
4,704
+15
| +0.3% | +$1.29K |
|
3057
A2Z Smart Technologies
AZ
$361M
| $287K | ﹤0.01% |
+43,300
| New | +$237K |
|
3058
Minerva Neurosciences
NERV
$187M
| $285K | ﹤0.01% |
128,100
-29,100
| -19% | -$68.7K |
|
3059
UTStarcom
UTSI
$23M
| $284K | ﹤0.01% |
98,029
-12,500
| -11% | -$34.7K |
|
3060
Bogota Financial
BSBK
$113M
| $284K | ﹤0.01% |
37,851
-800
| -2% | -$6.44K |
|
3061
Xilio Therapeutics
XLO
$59.6M
| $283K | ﹤0.01% |
21,187
+2,166
| +11% | +$29.8K |
|
3062
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.78B
| $283K | ﹤0.01% |
+5,800
| New | +$299K |
|
3063
Solid Power
SLDP
$545M
| $283K | ﹤0.01% |
149,600
-40,296
| -21% | -$49.8K |
|
3064
UNIFI
UFI
$127M
| $281K | ﹤0.01% |
45,000
-21,434
| -32% | -$131K |
|
3065
VanEck Intermediate Muni ETF
ITM
$2.14B
| $281K | ﹤0.01% |
6,100
-116,100
| -95% | -$5.38M |
|
3066
EVI Industries
EVI
$206M
| $281K | ﹤0.01% |
17,169
-1,821
| -10% | -$34.7K |
|
3067
Altisource Portfolio Solutions
ASPS
$64.5M
| $280K | ﹤0.01% |
53,315
-1,788
| -3% | -$13.3K |
|
3068
State Street Financial Select Sector SPDR ETF
XLF
$59.5B
| $280K | ﹤0.01% |
+5,800
| New | +$280K |
|
3069
Amplify CWP Enhanced Dividend Income ETF
DIVO
$7.85B
| $279K | ﹤0.01% |
6,900
-8,787
| -56% | -$365K |
|
3070
Lantern Pharma
LTRN
$33.9M
| $278K | ﹤0.01% |
87,300
+3,300
| +4% | +$11.3K |
|
3071
Gogoro
GGR
$49.4M
| $278K | ﹤0.01% |
27,799
-34,011
| -55% | -$367K |
|
3072
Arcus Biosciences
RCUS
$3.67B
| $275K | ﹤0.01% |
18,500
-165,400
| -90% | -$2.7M |
|
|
ETWO
3073
DELISTED
E2open Parent Holdings
ETWO
| $273K | ﹤0.01% |
102,600
+27,800
| +37% | +$87.4K |
|
3074
Spectral AI
MDAI
$50.5M
| $272K | ﹤0.01% |
+96,025
| New | +$152K |
|
3075
Brilliant Earth
BRLT
$22.1M
| $272K | ﹤0.01% |
129,400
+7,400
| +6% | +$13.6K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.